{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:05:20Z","timestamp":1789693520475,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Arterial hypertension drives coronary vascular remodeling, yet disentangling the independent effects of physiological aging and chronic hemodynamic overload on the endothelium (CD31) and glycocalyx (CD138) in situ remains challenging. Most clinical studies evaluate soluble circulating markers, while direct morphological evidence of tissue-level spatial degradation is scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This observational post-mortem study evaluated coronary artery fragments from 30 deceased patients (10 controls, 20 with essential hypertension) using immunohistochemistry and digital pathology. To mitigate confounding bias caused by age discrepancies and acute pre-mortem systemic stressors in the control group (e.g., fatal trauma), multivariable linear regression modeling with robust standard errors was applied exclusively to the hypertensive cohort to isolate the independent impacts of chronological age and hypertension duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Within the hypertensive cohort, chronological age emerged as a significant independent factor inversely associated with CD31 expression area (\u03b2 = -0.74, 95% CI: -0.98 to -0.50,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016). The duration of hypertension was not independently associated with CD31 loss (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.076). Furthermore, the multivariable model for CD138 did not reach overall statistical significance (for age: \u03b2 = -0.17, 95% CI: -0.42 to 0.07,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.200; for hypertension duration: \u03b2\u2009=\u20090.21, 95% CI: -0.06 to 0.48,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.130). However, a robust positive correlation was observed between CD31 and CD138 tissue expression levels (\n                      <jats:italic>R<\/jats:italic>\n                      \u2009=\u20090.50,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025), indicating synchronized structural degradation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Chronological age, rather than the chronicity of hypertension, is significantly associated with reduced CD31 expression in the coronary arteries of hypertensive patients. The positive correlation between CD31 and CD138 expression highlights a synchronized spatial degradation of the endothelium and its protective glycocalyx. These findings highlight the critical necessity of isolating physiological senescence from pathological remodeling in vascular research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-06210-z","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:32:16Z","timestamp":1782873136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age, rather than hypertension duration, drives coronary endothelial degradation: an in situ post-mortem analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8710-1271","authenticated-orcid":false,"given":"Oleh","family":"Samchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5998-9166","authenticated-orcid":false,"given":"Yevhen","family":"Panasyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8193-4941","authenticated-orcid":false,"given":"Vladyslav","family":"Bardash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3653-3177","authenticated-orcid":false,"given":"Orest","family":"Zolotukhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-0969","authenticated-orcid":false,"given":"Eugen","family":"Sklyarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-3429","authenticated-orcid":false,"given":"Igor","family":"Skrypnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"25","key":"6210_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"6210_CR2","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension. J Hypertens. 2023;41(12):1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480.","journal-title":"J Hypertens"},{"key":"6210_CR3","doi-asserted-by":"publisher","first-page":"798958","DOI":"10.3389\/fmed.2021.798958","volume":"8","author":"G Gallo","year":"2022","unstructured":"Gallo G, Volpe M, Savoia C. Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications. Front Med (Lausanne). 2022;8:798958. https:\/\/doi.org\/10.3389\/fmed.2021.798958.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"6210_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone MA Jr, Garc\u00eda-Carde\u00f1a G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016;118(4):620\u201336. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306301.","journal-title":"Circ Res"},{"issue":"1","key":"6210_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/cvr\/cvaa085","volume":"117","author":"Y Alexander","year":"2021","unstructured":"Alexander Y, Osto E, Schmidt-Trucks\u00e4ss A, Shechter M, Trifunovic D, Duncker DJ, et al. Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis. Cardiovasc Res. 2021;117(1):29\u201342. https:\/\/doi.org\/10.1093\/cvr\/cvaa085.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"6210_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s13239-020-00485-9","volume":"12","author":"S Weinbaum","year":"2021","unstructured":"Weinbaum S, Cancel LM, Fu BM, Tarbell JM. The Glycocalyx and Its Role in Vascular Physiology and Vascular Related Diseases. Cardiovasc Eng Technol. 2021;12(1):37\u201371. https:\/\/doi.org\/10.1007\/s13239-020-00485-9.","journal-title":"Cardiovasc Eng Technol"},{"issue":"18","key":"6210_CR7","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.3390\/ijms20184411","volume":"20","author":"A Kr\u00fcger-Genge","year":"2019","unstructured":"Kr\u00fcger-Genge A, Blocki A, Franke RP, Jung F. Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019;20(18):4411. https:\/\/doi.org\/10.3390\/ijms20184411.","journal-title":"Int J Mol Sci"},{"key":"6210_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.coph.2019.04.011","volume":"45","author":"DR Machin","year":"2019","unstructured":"Machin DR, Phuong TT, Donato AJ. The role of the endothelial glycocalyx in advanced age and cardiovascular disease. Curr Opin Pharmacol. 2019;45:66\u201371. https:\/\/doi.org\/10.1016\/j.coph.2019.04.011.","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"6210_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/biomedicines9040328","volume":"9","author":"TJ Sluiter","year":"2021","unstructured":"Sluiter TJ, van Buul JD, Huveneers S, Quax PHA, de Vries MR. Endothelial Barrier Function and Leukocyte Transmigration in Atherosclerosis. Biomedicines. 2021;9(4):328. https:\/\/doi.org\/10.3390\/biomedicines9040328.","journal-title":"Biomedicines"},{"issue":"9","key":"6210_CR10","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/ATVBAHA.121.313788","volume":"41","author":"Z Alvandi","year":"2021","unstructured":"Alvandi Z, Bischoff J. Endothelial-Mesenchymal Transition in Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2021;41(9):2357\u201369. https:\/\/doi.org\/10.1161\/ATVBAHA.121.313788.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"6210_CR11","doi-asserted-by":"publisher","first-page":"e70117","DOI":"10.1111\/aas.70117","volume":"69","author":"C Humble","year":"2025","unstructured":"Humble C, Sch\u00f8nemann-Lund M, Bruun-Rasmussen P, Bestle MH, Johansson PI, Poulsen LM, et al. Pro- and Anti-Inflammatory Responses and Clinical Outcomes in Critically Ill Patients With Endotheliopathy: A Cohort Study. Acta Anaesthesiol Scand. 2025;69(9):e70117. https:\/\/doi.org\/10.1111\/aas.70117.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"6210_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ajpath.2019.11.016","volume":"190","author":"S Dogn\u00e9","year":"2020","unstructured":"Dogn\u00e9 S, Flamion B. Endothelial Glycocalyx Impairment in Disease: Focus on Hyaluronan Shedding. Am J Pathol. 2020;190(4):768\u201380. https:\/\/doi.org\/10.1016\/j.ajpath.2019.11.016.","journal-title":"Am J Pathol"},{"issue":"3","key":"6210_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0310057X1704500305","volume":"45","author":"NL Pillinger","year":"2017","unstructured":"Pillinger NL, Kam P. Endothelial glycocalyx: basic science and clinical implications. Anaesth Intensive Care. 2017;45(3):295\u2013307. https:\/\/doi.org\/10.1177\/0310057X1704500305.","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"6210_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10522-025-10279-y","volume":"26","author":"Q Li","year":"2025","unstructured":"Li Q, Qian Z, Huang Y, et al. Mechanisms of endothelial senescence and vascular aging. Biogerontology. 2025;26(4):128. https:\/\/doi.org\/10.1007\/s10522-025-10279-y.","journal-title":"Biogerontology"},{"issue":"5","key":"6210_CR15","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1161\/HYPERTENSIONAHA.120.14971","volume":"76","author":"RM Bruno","year":"2020","unstructured":"Bruno RM, Nilsson PM, Engstr\u00f6m G, Wadstr\u00f6m BN, Empana JP, Boutouyrie P, et al. Early and Supernormal Vascular Aging: Clinical Characteristics and Association With Incident Cardiovascular Events. Hypertension. 2020;76(5):1616\u201324. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.14971.","journal-title":"Hypertension"},{"key":"6210_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fcvm.2019.00015","volume":"6","author":"H Zeng","year":"2019","unstructured":"Zeng H, Chen JX. Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med. 2019;6:15. https:\/\/doi.org\/10.3389\/fcvm.2019.00015.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"6210_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41569-022-00739-0","volume":"20","author":"SI Bloom","year":"2023","unstructured":"Bloom SI, Islam MT, Lesniewski LA, Donato AJ. Mechanisms and consequences of endothelial cell senescence. Nat Rev Cardiol. 2023;20(1):38\u201351. https:\/\/doi.org\/10.1038\/s41569-022-00739-0.","journal-title":"Nat Rev Cardiol"},{"key":"6210_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41392-025-02346-0","volume":"10","author":"MJ Herzog","year":"2025","unstructured":"Herzog MJ, M\u00fcller P, Lechner K, et al. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. Signal Transduct Target Ther. 2025;10:282. https:\/\/doi.org\/10.1038\/s41392-025-02346-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"6210_CR19","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1113\/JP270538","volume":"594","author":"S Costantino","year":"2016","unstructured":"Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol. 2016;594(8):2061\u201373. https:\/\/doi.org\/10.1113\/JP270538.","journal-title":"J Physiol"},{"issue":"3","key":"6210_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10522-025-10256-5","volume":"26","author":"A Picos","year":"2025","unstructured":"Picos A, Seoane N, Campos-Toimil M, Vi\u00f1a D. Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects. Biogerontology. 2025;26(3):118. https:\/\/doi.org\/10.1007\/s10522-025-10256-5.","journal-title":"Biogerontology"},{"key":"6210_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41514-024-00170-4","volume":"10","author":"MOJ Grootaert","year":"2024","unstructured":"Grootaert MOJ. Cell senescence in cardiometabolic diseases. NPJ Aging. 2024;10:46. https:\/\/doi.org\/10.1038\/s41514-024-00170-4.","journal-title":"NPJ Aging"},{"issue":"5","key":"6210_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ckj\/sfz042","volume":"12","author":"O Yilmaz","year":"2019","unstructured":"Yilmaz O, Afsar B, Ortiz A, Kanbay M. The role of endothelial glycocalyx in health and disease. Clin Kidney J. 2019;12(5):611\u20139. https:\/\/doi.org\/10.1093\/ckj\/sfz042.","journal-title":"Clin Kidney J"},{"issue":"12","key":"6210_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11883-017-0691-9","volume":"19","author":"R Mitra","year":"2017","unstructured":"Mitra R, O\u2019Neil GL, Harding IC, Cheng MJ, Mensah SA, Ebong EE. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target. Curr Atheroscler Rep. 2017;19(12):63. https:\/\/doi.org\/10.1007\/s11883-017-0691-9.","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"6210_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/jth.14371","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019;17(2):283\u201394. https:\/\/doi.org\/10.1111\/jth.14371.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"6210_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12882-020-02219-4","volume":"22","author":"H Liew","year":"2021","unstructured":"Liew H, Roberts MA, Pope A, McMahon LP. Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction. BMC Nephrol. 2021;22(1):21. https:\/\/doi.org\/10.1186\/s12882-020-02219-4.","journal-title":"BMC Nephrol"},{"issue":"8","key":"6210_CR26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/CM9.0000000000000177","volume":"132","author":"RN Cao","year":"2019","unstructured":"Cao RN, Tang L, Xia ZY, Xia R. Endothelial glycocalyx as a potential therapeutic target in organ injuries. Chin Med J (Engl). 2019;132(8):963\u201375. https:\/\/doi.org\/10.1097\/CM9.0000000000000177.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"6210_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","volume":"23","author":"R Uchimido","year":"2019","unstructured":"Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019;23(1):16. https:\/\/doi.org\/10.1186\/s13054-018-2292-6.","journal-title":"Crit Care"},{"issue":"4","key":"6210_CR28","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1002\/cphy.c210029","volume":"12","author":"CA Foote","year":"2022","unstructured":"Foote CA, Soares RN, Ramirez-Perez FI, Ghiarone T, Aroor A, Manrique-Acevedo C, et al. Endothelial Glycocalyx Compr Physiol. 2022;12(4):3781\u2013811. https:\/\/doi.org\/10.1002\/cphy.c210029.","journal-title":"Endothelial Glycocalyx Compr Physiol"},{"issue":"24","key":"6210_CR29","doi-asserted-by":"publisher","first-page":"13294","DOI":"10.3390\/ijms252413294","volume":"25","author":"A Durante","year":"2024","unstructured":"Durante A, Mazzapicchi A, Baiardo Redaelli M. Systemic and Cardiac Microvascular Dysfunction in Hypertension. Int J Mol Sci. 2024;25(24):13294. https:\/\/doi.org\/10.3390\/ijms252413294.","journal-title":"Int J Mol Sci"},{"key":"6210_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-023-01430-7","volume":"8","author":"J Ma","year":"2023","unstructured":"Ma J, Li Y, Yang X, et al. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:168. https:\/\/doi.org\/10.1038\/s41392-023-01430-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"6210_CR31","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.121.17954","volume":"79","author":"D Rizzoni","year":"2022","unstructured":"Rizzoni D, Mengozzi A, Masi S, Agabiti Rosei C, De Ciuceis C, Virdis A. New Noninvasive Methods to Evaluate Microvascular Structure and Function. Hypertension. 2022;79(5):874\u201386. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17954.","journal-title":"Hypertension"},{"issue":"15","key":"6210_CR32","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.3390\/jcm12154892","volume":"12","author":"D Rizzoni","year":"2023","unstructured":"Rizzoni D, Agabiti-Rosei C, Boari GEM, Muiesan ML, De Ciuceis C. Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease? J Clin Med. 2023;12(15):4892. https:\/\/doi.org\/10.3390\/jcm12154892.","journal-title":"J Clin Med"},{"issue":"10","key":"6210_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ajh\/hpy083","volume":"31","author":"P Martinez-Quinones","year":"2018","unstructured":"Martinez-Quinones P, McCarthy CG, Watts SW, Klee NS, Komic A, Calmasini FB, et al. Hypertension Induced Morphological and Physiological Changes in Cells of the Arterial Wall. Am J Hypertens. 2018;31(10):1067\u201378. https:\/\/doi.org\/10.1093\/ajh\/hpy083.","journal-title":"Am J Hypertens"},{"key":"6210_CR34","doi-asserted-by":"publisher","first-page":"100919","DOI":"10.1016\/j.ajpc.2024.100919","volume":"21","author":"AA Chandra","year":"2024","unstructured":"Chandra AA, Espiche C, Maliha M, Virani SS, Blumenthal RS, Rodriguez F, et al. American society for preventive cardiology 2024 cardiovascular disease prevention: Highlights and key sessions. Am J Prev Cardiol. 2024;21:100919. https:\/\/doi.org\/10.1016\/j.ajpc.2024.100919.","journal-title":"Am J Prev Cardiol"},{"key":"6210_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yjmcc.2015.04.011","volume":"83","author":"A Harvey","year":"2015","unstructured":"Harvey A, Montezano AC, Touyz RM. Vascular biology of ageing\u2014Implications in hypertension. J Mol Cell Cardiol. 2015;83:112\u201321. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.04.011.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"6210_CR36","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/CIRCRESAHA.121.318061","volume":"128","author":"P Boutouyrie","year":"2021","unstructured":"Boutouyrie P, Chowienczyk P, Humphrey JD, Mitchell GF. Arterial Stiffness and Cardiovascular Risk in Hypertension. Circ Res. 2021;128(7):864\u201386. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318061.","journal-title":"Circ Res"},{"key":"6210_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.matbio.2016.09.003","volume":"57\u201358","author":"MA Gubbiotti","year":"2017","unstructured":"Gubbiotti MA, Neill T, Iozzo RV. A current view of perlecan in physiology and pathology: A mosaic of functions. Matrix Biol. 2017;57\u201358:285\u201398. https:\/\/doi.org\/10.1016\/j.matbio.2016.09.003.","journal-title":"Matrix Biol"},{"issue":"1","key":"6210_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/joim.12465","volume":"280","author":"JM Tarbell","year":"2016","unstructured":"Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med. 2016;280(1):97\u2013113. https:\/\/doi.org\/10.1111\/joim.12465.","journal-title":"J Intern Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06210-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06210-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06210-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:47:13Z","timestamp":1789692433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06210-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6210"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06210-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9463271\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and current Ukrainian legislation regarding bioethics and human tissue research. The research protocol, including the retrospective collection of clinical data and the use of post-mortem tissue samples, was reviewed and officially approved by the Institutional Ethics Committee of Danylo Halytsky Lviv National Medical University (Protocol Number: No. 10, Date of Approval: September 10, 2023). Since the study utilized anonymized, archived autopsy material obtained during standard pathological or forensic procedures, the requirement for direct informed consent was waived by the Ethics Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"813"}}